ICCC 8-K 2026-10-13

IMMUCELL CORP /DE/ (ICCC) 8-K dated 2026-10-13 — accession 0001437749-26-032465. This URL is the filing, not the ICCC hub.

IMMUCELL CORP /DE/ (ICCC) is a biotechnology company listed on US.

ICCC: SECURITIES AND EXCHANGE COMMISSION

Cached items: 2.02, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported ICCC revenue for 2025-12-31 was $27.6M. Net income was -$1.0M. Revenue was up 58.2% from 2023-12-31 to 2025-12-31. ICCC currently screens at market cap $58.9M.

Not investment advice. The ICCC SEC hub lists recent forms. The stock page is the research view.